Diabetes is not a one-time diagnosis — it is a daily management process. How well you control your blood sugar directly determines whether serious complications develop over the next 5–10 years: kidney damage, vision loss, nerve damage, and cardiovascular disease. Regular laboratory monitoring is your most powerful tool in this process.
This guide covers every blood test relevant to type 1 and type 2 diabetes management. We explain what to test monthly, quarterly, and annually, which markers track sugar control and complication risk, and how to prepare for and interpret each result.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Monitoring schedules and target values are individualized based on diabetes type, age, comorbidities, and treatment plan. If you have persistently high blood sugar, hypoglycemic episodes, or worsening vision, do not wait for a routine visit — see your doctor promptly.
Type 1 vs. Type 2: How Monitoring Differs
Before diving into specific tests, it helps to understand the key difference.
Type 1 diabetes is an autoimmune destruction of the pancreatic beta cells. The body produces little to no insulin, requiring lifelong insulin therapy. Monitoring focuses on precise insulin dosing and preventing both diabetic ketoacidosis and hypoglycemia.
Type 2 diabetes involves insulin resistance — the body produces insulin, but cells respond poorly. It is more common in adults and is associated with excess weight, sedentary lifestyle, and genetics. Monitoring focuses on reducing insulin resistance, managing weight, and adjusting medications as needed.
The core test panel is nearly identical for both types, but the emphasis shifts: type 1 prioritizes daily self-monitoring and C-peptide, while type 2 focuses on HOMA-IR, the lipid panel, and insulin resistance assessment.
Daily Self-Monitoring of Blood Glucose
This is not a lab test, but it is a mandatory part of diabetes care. All patients should measure glucose with a fingerstick glucometer or a continuous glucose monitor (CGM).
- Type 1 on insulin: At least 4 times daily (fasting, before meals, bedtime), or more frequently. Many use CGM systems.
- Type 2 on oral medications: 1–2 times daily at varying times, or several days per week.
- Type 2 on insulin: Similar to type 1, at least 3–4 times daily.
Self-monitoring does not replace lab tests — it shows the "here and now," while laboratory markers reflect long-term control.
Quarterly Panel: 4 Key Tests
This block is tested every 3 months and forms the foundation of long-term monitoring.
1. HbA1c (Glycated Hemoglobin)
The gold standard of diabetes control. It reflects your average blood sugar over 2–3 months — the lifespan of red blood cells.
- Normal (no diabetes): Below 5.7%
- Prediabetes: 5.7–6.4%
- Diabetes: 6.5% and above
- ADA target for most adults with diabetes: Below 7% (below 6.5% for younger patients without complications; up to 8% for older adults with significant comorbidities)
HbA1c is unaffected by what you ate today, so fasting is not required. Labs such as Quest Diagnostics and LabCorp include it in standard diabetes panels.
2. Fasting Plasma Glucose (FPG)
A baseline marker always tested alongside HbA1c.
- Normal: 70–99 mg/dL (3.9–5.5 mmol/L)
- Prediabetes: 100–125 mg/dL (5.6–6.9 mmol/L)
- Diabetes: 126 mg/dL (7.0 mmol/L) and above
- Target for most patients with diabetes: 80–130 mg/dL (4.4–7.2 mmol/L)
Drawn in the morning after an 8–12 hour fast. Water is permitted.
3. Fructosamine
An alternative to HbA1c for shorter intervals — it reflects average glucose over the past 2–3 weeks. Useful when HbA1c is unreliable: during pregnancy, hemolytic anemia, or after blood transfusion.
- Normal: 205–285 micromol/L
- Satisfactory diabetes control: Below 286 micromol/L
- Decompensation: Above 320 micromol/L
Ordered by your physician as needed; it is not part of the standard quarterly panel.
4. Complete Blood Count (CBC)
Monitors overall health, screens for anemia (which can falsely raise or lower HbA1c), and detects signs of hidden infection — a common concern in diabetes. For a full breakdown, see our CBC interpretation guide.
Semi-Annual Panel: Screening for Complications
This block is tested every 6 months, or more frequently if complications are present.
1. Kidney Function Panel
Diabetic nephropathy is one of the most common and dangerous complications. Key markers:
- Serum creatinine: Used to calculate eGFR. Normal eGFR is above 90 mL/min/1.73m2. A drop below 60 warrants serious attention.
- BUN (blood urea nitrogen): Normal 7–20 mg/dL.
A comprehensive metabolic panel at Quest Diagnostics or LabCorp covers these markers. For full details, see our blood chemistry guide.
2. Urine Albumin-to-Creatinine Ratio (UACR)
The earliest marker of diabetic kidney disease. It detects microalbuminuria long before creatinine rises in the blood.
- Normal: Below 30 mg/g creatinine
- Microalbuminuria: 30–300 mg/g — early nephropathy, requires intensified glucose control and often ACE inhibitors or ARBs
- Macroalbuminuria: Above 300 mg/g — significant kidney damage
The ADA recommends annual screening for all patients. If microalbuminuria is detected, testing every 6 months is advised.
3. Lipid Panel
Cardiovascular risk is significantly elevated in diabetes. Lipid monitoring is a mandatory part of prevention.
- Total cholesterol: Desirable below 200 mg/dL
- LDL ("bad" cholesterol): ADA target for diabetes below 100 mg/dL; below 70 mg/dL if high cardiovascular risk
- HDL ("good" cholesterol): Above 40 mg/dL for men, above 50 mg/dL for women
- Triglycerides: Below 150 mg/dL
For a deeper dive, see our comprehensive blood chemistry guide.
4. Liver Function Tests
Non-alcoholic fatty liver disease (NAFLD) is common in type 2 diabetes. Monitoring is essential.
- ALT: Normal up to 40 IU/L
- AST: Normal up to 40 IU/L
- GGT: Normal up to 50 IU/L for men, up to 35 IU/L for women
5. Urinalysis
Detects glucosuria, ketones, and urinary tract infections — all common issues in diabetes. For a full guide, see our urinalysis interpretation article.
Annual Panel: Deep Assessment
Once a year, an expanded panel captures the bigger picture.
1. C-Peptide and Fasting Insulin
These tests measure how much insulin your pancreas still produces.
- Fasting insulin: Normal approximately 2.6–24.9 microIU/mL
- C-peptide: Normal 0.9–7.1 ng/mL (Quest Diagnostics reference range)
In type 1 diabetes, C-peptide is typically low or undetectable. In type 2, it is often normal or elevated (indicating insulin resistance). These tests help:
- Differentiate diabetes type
- Assess residual beta-cell function
- Determine whether insulin therapy is needed
2. HOMA-IR (Insulin Resistance Index)
A calculated index: fasting glucose (mg/dL) x fasting insulin (microIU/mL) / 405.
- Normal: Below 2.0
- Insulin resistance: Above 2.5
Particularly useful in type 2 diabetes and prediabetes to evaluate the effectiveness of lifestyle changes. For more on metabolic testing before lifestyle interventions, see our blood tests before weight loss guide.
3. Vitamin D (25-OH)
Vitamin D deficiency in people with diabetes is associated with poorer glucose control and more frequent complications.
- Deficiency: Below 20 ng/mL
- Insufficiency: 20–30 ng/mL
- Target: 30–60 ng/mL
Supplementation doses should be determined by your healthcare provider.
4. TSH (Thyroid Function)
In type 1 diabetes, the risk of autoimmune thyroiditis is significantly elevated. In type 2, hypothyroidism can worsen glucose control.
- TSH normal range: 0.4–4.0 mIU/L
For a thorough breakdown, see our thyroid test interpretation guide.
5. Calcium, Magnesium, Ferritin
- Calcium (total): Normal 8.6–10.2 mg/dL
- Magnesium: Often low in diabetes; correction improves insulin sensitivity
- Ferritin: Assesses iron stores. Low ferritin can mask or distort HbA1c values
6. Non-Lab Annual Checks
These are not blood tests but are mandatory parts of annual diabetes care:
- ECG — yearly cardiovascular assessment
- Dilated eye exam — screening for diabetic retinopathy
- Foot examination — screening for diabetic neuropathy and ulcers
Monitoring Schedule at a Glance
| Test |
Frequency |
| Self-monitoring of blood glucose |
Daily (per your doctor's plan) |
| HbA1c + fasting glucose |
Every 3 months |
| CBC |
Every 3–6 months |
| Metabolic panel (creatinine, eGFR, liver) |
Every 6 months |
| Lipid panel |
Every 6–12 months |
| Urine albumin-to-creatinine ratio |
Every 6–12 months |
| Urinalysis |
Every 6 months |
| C-peptide, insulin, HOMA-IR |
Annually or as indicated |
| TSH |
Annually |
| Vitamin D |
Annually |
| ECG, dilated eye exam, foot exam |
Annually |
If control is poor or complications emerge, frequency increases — your endocrinologist determines the final schedule.
How to Prepare for Your Tests
Proper preparation is especially important in diabetes:
- Fasting glucose and HOMA-IR require strict fasting — 8–12 hours without food. Water is fine.
- HbA1c can be drawn at any time — meals do not affect it.
- Do not skip your morning insulin or medications unless your doctor says otherwise.
- Urine albumin: First morning void, midstream catch.
- Avoid alcohol for 1–3 days before — it distorts liver enzymes and lipids.
- No intense exercise for 12–24 hours — it affects glucose and lipids.
- If you are sick or stressed, postpone routine labs by 1–2 weeks.
How to Interpret Your Results
Several common scenarios:
- HbA1c 6.8%, fasting glucose 117 mg/dL — at target for most patients; continue current therapy.
- HbA1c 9% despite "good" glucometer readings — check meter accuracy and look for postprandial spikes.
- HbA1c 5.5% with hypoglycemic episodes — control is too tight; therapy needs loosening, especially in older adults.
- UACR 50 mg/g — early nephropathy; discuss kidney protection with your endocrinologist or nephrologist.
- LDL 135 mg/dL with diabetes — above target; discuss statin therapy.
- C-peptide near zero + young age + ketones — type 1 diabetes; treatment strategy differs fundamentally from type 2.
When to See a Doctor Urgently
Contact your endocrinologist promptly if:
- HbA1c has jumped 1% or more in a quarter — serious decompensation.
- Recurrent hypoglycemia — sweating, tremor, hunger, confusion.
- Fasting glucose consistently above 180 mg/dL or single readings above 270 mg/dL.
- New swelling, changes in urination, decreased urine output — signs of nephropathy.
- Vision changes, floaters, or flashes — need a dilated eye exam.
- Numbness, burning, or tingling in feet — signs of neuropathy.
- Non-healing wounds or sores on feet — risk of diabetic foot ulcer.
- Severe illness or infection — may require temporary therapy adjustment.
If you are planning surgery, see our pre-surgery blood tests guide — patients with diabetes have an expanded preoperative panel. For general yearly health screening, check our annual health checkup guide.
Get Your Results Interpreted
Understanding your lab results is the first step toward better diabetes management. If you have recent blood work and want a clear, personalized explanation of every value, upload your results at Evallume for an instant AI-powered interpretation tailored to your age, sex, and condition.
This article is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Consult a healthcare professional for any medical concerns.
